cost-effectivenessACE inhibitorssimvastatinThe treatment of hypertension by costly new drugs such as the angiotensin converting enzyme inhibitors, means that careful monitoring of health care expenditure is essential. If drugs like simvastatin come to be widely used, costs will mount even more. New ...
(3)Whatistheproblemofthenewdrugaccordingtotheauthorasanacademic? ___A.Theeffectivenessmaybeblownupwithoutfairassessment.B.Ithastheseriousside-effectssuchasbrainbleedinganddeaths.C.Thecostofthenewdrugisoutofreachforordinarypeople.D.ThereisnopossibilityfornewdrugstobeadmittedintotheNHS.(4)Whatistheauthor'satti...
The Truth Behind the Cost of New Drugs. California: University of California Press; 2004.Goozner M, 2004. The $800 Million Pill. University of California Press, Berkeley, CA.Goozner, M., The $800 Million Pill, Berkeley: ... Hurter,B. - 《Psychiatric Services》 被引量: 122发表: 2006...
Drugmakershave a pointwhen they say that the cost of developing new drugs for non-lucrative ailments is prohibitive. 这句话的意思是:制药商说开发针对“无利可图”疾病的新药,其成本令人望而却步,在这一点上他们说得有道理。Have a point是一个固定表达,意思相当于have made a good point,即“(某观点...
Companies often argue that their prices take into account research and development costs and that they practice tiered pricing, which allows poorer countries to pay less, subsidized by higher prices in wealthy countries. However, the cost of R&D for these medicines and vaccines is never made public...
The first drug purporting to slow the advance of Alzheimer's disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the lower-income seniors most likely to suffer from dementia. ...
The cost of drug development has risen markedly in the past 30 years, with studies now reporting values exceeding US $800 million. As these spiralling costs threaten to make the development of new drugs increasingly unaffordable for both developing companies and consumers, it is clear that efforts...
Re: High cost of new drugs - Recognize the pivotal role of the private sectordoi:10.1136/bmj.i4136BMJ
Childhood Cancer Survivorship: Improving Care and Quality of Life Only more recently has it been realized that the intense effort to care for and cure a child with cancer does not end with survival. Continued surveillance... SJ Bottomley - 《Lancet Oncology》 被引量: 908发表: 2003年 Turning ...
Most analysts are basing the cost of molnupiravir on the $1.2 billion the U.S. government spent to lock up 1.7 million courses of the medicine, which works out to $700 per five day course. But Anderson points out that the cost for a new pill to treat influenza developed by Roche is...